Intensity Therapeutics, Inc.'s total assets for Q4 2025 were $14.10M, an increase of 47.12% from the previous quarter. INTS total liabilities were $2.23M for the fiscal quarter, a -5.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.